enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. ‘A huge shock to the system’: Doctors warn about asthma ...

    www.aol.com/huge-shock-system-doctors-warn...

    GSK did price the authorized generic lower than branded Flovent; one package of Flovent HFA in the 110 microgram dose, for example, costs $273.83, about 50% more than the $177.99 wholesale ...

  3. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...

    www.aol.com/news/popular-asthma-inhaler...

    The discontinuation aligns with a change to Medicaid rebates that may have had the inhaler’s manufacturer selling the drug at a loss. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...

  4. Parents search for Flovent alternatives as childhood asthma ...

    www.aol.com/parents-search-flovent-alternatives...

    Flovent, one of the most commonly prescribed childhood asthma inhalers, is no longer being manufactured in the United States.. This preventative medication is usually taken every day to help keep ...

  5. Fluticasone propionate - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_propionate

    Fluticasone propionate, sold under the brand names Flovent and Flonase among others, is a glucocorticoid steroid medication. [8] When inhaled it is used for the long term management of asthma and COPD . [ 8 ]

  6. List of withdrawn drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_withdrawn_drugs

    Diversion, abuse, and a relatively high rate of overdose deaths in comparison to other drugs of its group. This drug continues to be available in most of the world including the US, but under strict controls. Terfenadine (Seldane, Triludan) 1997–1998 France, South Africa, Oman, others, US Prolonged QT interval; ventricular tachycardia [2] [3]

  7. Fluticasone - Wikipedia

    en.wikipedia.org/wiki/Fluticasone

    Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. [1] [2] [3] [4] [5] Both the esters, fluticasone propionate (sold as Flovent) and ...

  8. GSK's asthma drug Nucala meets main goal in study on ... - AOL

    www.aol.com/news/gsks-asthma-drug-nucala-meets...

    Patients treated with Nucala and an inhaled maintenance therapy for up to 104 weeks had a lower annualised rate of moderate or severe exacerbations than those given a placebo, GSK said.

  9. Almorexant - Wikipedia

    en.wikipedia.org/wiki/Almorexant

    Almorexant (), also known by its development code ACT-078573, is an orexin antagonist, acting as a competitive antagonist of the OX 1 and OX 2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. [3]